Researchers sought to determine whether the CAR-T therapy volamcabtagene durzigedleucel (CTX130) would be effective in patients with T-cell lymphoma.

CHI Mercy Hospital proudly announces their plans to open its own chemo infusion center, a project made possible by the ...

VALLEY CITY, N.D. — CHI Mercy Hospital announced it plans to open a chemo infusion center and will hold a dedication ceremony for the project at noon on Friday, Feb. 21, at the hospital. The hospital ...

RenovoRx (NASDAQ: RNXT) , a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath(R), a novel, FDA-cleare ...

"Only a patient can really appreciate how much ringing the bell matters. So the day he hung it up, it was the most joyous ...

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application ...

SSM Health said home-based skilled nursing reduced hospital readmissions and hospital stays for about 50 patients in ...

It's mid-morning and it's time for Dr. Gus, M.D. to make the rounds at Baptist Health Lexington. Gus really isn't a doctor; ...

The Global Implantable Drug Delivery Devices Market was valued at USD 26.7 Bn in 2023. It is expected to reach USD 57.1 Bn by 2033, with a CAGR of 8.1% ...

AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart ...

Let’s dig into the relative performance of The Pennant Group (NASDAQ:PNTG) and its peers as we unravel the now-completed Q3 ...

Cancer experts at Providence Saint Joseph Medical Center came together in the early 2000s with a common vision — to build one ...